The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit ...

Indian pharma stocks fell 1.6% on Monday (May 12, 2025), bucking broader market gains, after U.S. President Donald Trump said he would cut drug prices by 30%–80% to match other wealthy nations.

BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Monday reported a loss of $65 million in its first quarter. On a per-share basis ...

Shares of global pharma stocks slumped on Monday after President Trump vowed to cut drug prices for Americans by as much as 80%. Novo Nordisk, which generates around 60% of its sales in the U.S ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

ACADIA Pharmaceuticals posted better-than-expected Q1 results earlier this month. The company has a rock solid balance sheet and advancing a couple of key drug candidates within its pipeline.

As pharmaceutical investors see it, he instead stomped loudly and wielded a wet noodle. Trump’s social media bluster that he would peg U.S. drug prices to those in other countries was enough to ...

Lantern Pharma receives FDA clearance to begin Phase 1b/2 trial of LP-184 in advanced NSCLC patients with key mutations and ...

The Nifty Pharma index was the only sectoral index that opened in the red, amid an across-the-board rally. Pharma stocks, however, recovered lost ground, and the Nifty Pharma closed marginally ...

Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.03 per share a year ago.

The collaboration marks Cloud’s first big pharma deal, but for GSK it adds to the $33 million deal it signed with Scotland’s ExScientia last year to apply that firm’s AI technology to speed ...

The Track version is only available in the U.S. The onset of COVID-19 caused northern Italy-based Pirelli to rethink the way it designs ... to that used by the pharmaceutical industry.